ArticlePDF Available

A comparative study of severity scoring systems in acute pancreatitis

Authors:

Abstract and Figures

Objective: To investigate the prognostic and clinical usefulness of existing scoring systems in predicting the severity of acute pancreatitis (AP). Methods: This prospective, observational clinical study included patients with diagnosed AP. Ranson's, bedside index for severity in acute pancreatitis (BISAP) and PANC 3 scoring systems were used to stratify the severity of disease. Scores from each model were compared to clinical severity. Sensitivity, specificity and accuracy were computed for each model. A p<0.05 was considered statistically significant. Results: Of 54 patients, 25 patients had non-biliary (group I) and 29 patients had biliary pancreatitis (group II). Based on Ranson's scoring, 32% and 27.6% in group I and II were classified as severe pancreatitis whereas the calculated BISAP score predicted severe condition in 24% and 20.7% in group I and II (p=0.77). BISAP was the most accurate (78%) in predicting organ failure, followed by Ranson's (72%) and PANC 3 (65%). Accuracy of BISAP, Ranson's and PANC 3 scoring systems were 91%, 69% and 79.62%, respectively for predicting disease severity. Conclusion: It was seen that BISAP was better than Ranson's in assessing organ failure, mortality and clinical severity in terms of sensitivity, specificity, PPV, NPV and accuracy.
Content may be subject to copyright.
~ 237 ~
International Journal of Surgery Science 2020; 4(2): 237-241
E-ISSN: 2616-3470
P-ISSN: 2616-3462
© Surgery Science
www.surgeryscience.com
2020; 4(2): 237-241
Received: 19-02-2020
Accepted: 21-03-2020
Meghana Taggarsi
Sagar Hospitals, Jayanagar ‘T’
Block, Tilaknagar, Bangalore,
India
Anil Kumar
Sagar Hospitals, Jayanagar ‘T’
Block, Tilaknagar, Bangalore,
India
HR Ravishankar
MBBS, M.S, DNB, FRCS Eng,
FRCS (Gastro), CCST
Consultant Gastrointestinal and
Laparoscopic Surgeon, Head of
Department of General Surgery,
Sagar Hospitals, Jayanagar,
Tilaknagar, Bangalore, India
Corresponding Author:
HR Ravishankar
MBBS, M.S, DNB, FRCS Eng,
FRCS (Gastro), CCST
Consultant Gastrointestinal and
Laparoscopic Surgeon, Head of
Department of General Surgery,
Sagar Hospitals, Jayanagar,
Tilaknagar, Bangalore, India
A comparative study of severity scoring systems in acute
pancreatitis
Meghana Taggarsi, Anil Kumar and HR Ravishankar
DOI: https://doi.org/10.33545/surgery.2020.v4.i2d.424
Abstract
Objective: To investigate the prognostic and clinical usefulness of existing scoring systems in predicting
the severity of acute pancreatitis (AP).
Methods: This prospective, observational clinical study included patients with diagnosed AP. Ranson’s,
bedside index for severity in acute pancreatitis (BISAP) and PANC 3 scoring systems were used to stratify
the severity of disease. Scores from each model were compared to clinical severity. Sensitivity, specificity
and accuracy were computed for each model. A p<0.05 was considered statistically significant.
Results: Of 54 patients, 25 patients had non-biliary (group I) and 29 patients had biliary pancreatitis (group
II). Based on Ranson’s scoring, 32% and 27.6% in group I and II were classified as severe pancreatitis
whereas the calculated BISAP score predicted severe condition in 24% and 20.7% in group I and II
(p=0.77). BISAP was the most accurate (78%) in predicting organ failure, followed by Ranson’s (72%) and
PANC 3 (65%). Accuracy of BISAP, Ranson’s and PANC 3 scoring systems were 91%, 69% and 79.62%,
respectively for predicting disease severity.
Conclusion: It was seen that BISAP was better than Ranson’s in assessing organ failure, mortality and
clinical severity in terms of sensitivity, specificity, PPV, NPV and accuracy.
Keywords: acute pancreatitis, BISAP, PANC3, accuracy
1. Introduction
Acute pancreatitis (AP) is an inflammatory process with a variable clinical course and most
patients with AP present a mild disease that can be resolved spontaneously. However, despite
critical care, 10%-20% of patients experience a severe attack with high mortality up to 30% [1, 2].
In case of mild to moderate pancreatitis, mortality is less than 5%, although, 30% of them
develop secondary infection [3-4 weeks later than onset], which increases the mortality rate [3].
Ever since its establishment, the Atlanta Classification has been considered the global standard
tool for the assessment of AP severity [4]. Nonetheless, with time and varying clinical
representation, the Atlanta classification was revised with an emphasis on persistent organ
failure in 2012 [5].
Therefore, it is of foremost importance to assess the severity and identify patients at risk for an
early intensive therapy and timely intervention, and also, it has been shown to improve
prognosis and survival.
In this context, various multi-factorial scoring systems including Ranson’s [6] and Acute
Physiology and Chronic Health Evaluation (APACHE)-II scores [7] have been validated and used
for assessment of the severity of AP. However, due to their complex [8-10], a new prognostic
scoring system, the Bedside Index for Severity in Acute Pancreatitis (BISAP), was recently
proposed as an accurate and simple method for early identification of patients at risk of in-
hospital mortality [11, 12]. Although various scoring models exist to clinically evaluate the severity
of AP and organ failure, hitherto no single system has been considered ideal, thereby influencing
surgeon’s preference of choosing a method for prognostic assessment of AP. With this
background, we performed a study to compare the accuracy of Ranson’s criteria, BISAPs and
PANC 3 scoring systems in predicting the severity of an attack of AP.
2. Methods
This prospective comparative observational clinical study was conducted from May 2015 to
April 2017 in Sagar hospitals, a tertiary referral healthcare in Bangalore, India.
International Journal of Surgery Science http://www.surgeryscience.com
~ 238 ~
The study protocol was approved by the institutional ethical
committee. The diagnosis of Acute pancreatitis was made based
on history, clinical examination, laboratory values of serum
amylase and lipase, and imaging study ultrasound of abdomen,
to study the pancreas as well as to rule out or confirm biliary
cause for pancreatitis. The presence of any 2 of the 3 criteria was
diagnostic of pancreatitis.
Patients aged 18 years and above, diagnosed of AP (either first
attack or recurrent attacks), presenting with acute onset of
persistent severe epigastric pain, with or without radiation, and
increased serum amylase and lipase levels were included. On the
other hand, patients with pre-existing chronic pancreatitis or
with co-existing local complications of pancreatitis, cardiac
failure, liver failure, renal failure or any lung pathology were
excluded.
2.1 Assessment of severity and associated complications
Ranson’s, BISAPs and PANC 3 scoring systems were used to
stratify the severity of disease, within 48 hours of admission
(Table 1). The scores obtained from each of the scoring system
were compared to the clinical severity, as defined by Revised
Atlanta Classification 2012.
A score of ≥ 3 in first 48 hours for Ranson’s and first 24 hours
for BISAP indicated a likely severe pancreatitis condition.
Table 1: Description of parameters for BISAP and PANC 3 models
BISAPS
PANC 3
BUN
HCT
Mental status
BMI
SIRS
Chest X-Ray
Age
Pleural effusion
BMI: body mass index; BUN: blood urea nitrogen; HCT: haematocrit;
SIRS:
Data pertaining to duration of nil per oral, absence, presence or
persistence of organ failure, local complications, need for
interventions, ICU care, in-hospital mortality and length of
hospital stay was collected prospectively for each patient and
clinical severity was assessed.
Organ failure was defined according to the Marshall scoring
system. Respiratory (PaO2/FIO2), renal (serum creatinine) and
cardiovascular organ (systolic blood pressure) functions were
scored from 0-4. A score of 2 or more, involving one or more
than 1 organ, which may be persistent, lasting for more than 48
hours or transient, lasting for not more than 48 hours was
considered as organ failure. The clinical severity was assessed
during the course in the hospital, according to Revised Atlanta
classification 2012.
2.2 Statistical methods
Descriptive statistics was used to present continuous
measurements as mean ± standard deviation (SD) and
categorical measurements were presented as number and
percentages (%). Student t test was used to compare parameters
between two groups for continuous variables and Chi-square/
Fisher Exact test was used for categorical parameters.
Sensitivity, specificity, positive predictive value (PPV), negative
predictive value (NPV) and accuracy were computed to find the
diagnostic properties of Ranson’s, BISAP and PANC 3 scoring
to predict the severity of disease. SPSS 18.0, and R environment
ver.3.2.2 were used for the analysis. A p<0.05 was considered as
significant.
3. Results
A total of 54 patients (age range: 18 - 82 years) were included in
the study, of which 25 patients had non-biliary (group I, mean
age: 41.3±14.7 years) pancreatitis, and 29 patients had biliary
pancreatitis (group II, mean age: 55.6±14.7 years). However, all
the 54 patients were considered as a single group to draw
inference regarding outcomes of the scoring systems.
It was seen that the disease was more common in men (n=35)
than in women (n=19), although non-biliary pancreatitis was
more common in men (76% vs. 55.2%), while biliary
pancreatitis was more common in women (44.8% vs. 24%).
Biochemical parameters for two groups are presented in Table 2.
Table 2: Demographic and biochemical characters in two groups of
patients
Variables
Group I
Group II
PCV day1
39.93±6.31
39.67±5.80
PCV day2
36.57±6.91
36.79±5.84
TLC
14090.40±4959.24
12980.69±4972.59
BUN day 1
13.96±10.57
13.76±7.10
BUN day 2
15.84±12.3
15.24±7.06
RBS (mg/dl)
161.16±73.98
159.55±66.98
AST
106.68±167.02
207.31±200.02*
Calcium
8.46±0.88
8.71±0.67
Fluid sequestration
1201.80±669.53
1210.34±783.78
BMI (kg/m2)
26.14±5.50
26.29±4.45
PCV: packed cell volume; TLC: total leukocyte count; BUN: blood
urea nitrogen; RBS: random blood sugar; AST: aspartate
aminotransferase; BMI: body mass index
Based on Ranson’s scoring, 32% in group I and 27.6% in group
II were classified as severe pancreatitis whereas the calculated
BISAP score predicted severe condition in 24% of patients in
group I and 20.7% in group II (P=0.77). It was seen that all 54
patients had a PANC 3 score of less than 3, suggesting that each
of them would have mild or moderately severe pancreatitis.
PANC 3 score did not predict any cases to be severe in our study
(Table 3).
Table 3: Score code distribution among patients
Ranson's score code
Group I
Mild/ moderately severe (<3)
17 (68%)
Severe pancreatitis (>/=3)
8 (32%)
BISAP score
Mild/moderately severe (<3)
19 (76%)
Severe (>/=3)
6(24%)
PANC 3 score
Mild/moderately severe (<3)
25(100%)
Severe (=3)
0 (0)
As per revised Atlanta Classification 2012, 35 patients (64.8%)
of 54 had mild pancreatitis, 8 (14.8%) had moderately severe
and 11 (20.4%) had a severe disease (Table 4).
Table 4: Clinical (actual) severity analysis
Actual Severity
Group I
Group II
Not severe (mild + moderately severe)
19 (76%)
24 (82.7%)
Severe
6(24%)
5(17.2%)
Among the three scoring systems, BISAP was the most accurate
(78%) in predicting organ failure, with Ranson’s having an
accuracy of 72%, and PANC 3 depicted least accuracy (65%),
Graph 1
International Journal of Surgery Science http://www.surgeryscience.com
~ 239 ~
Graph 1: Performance of Ranson’s, BISAP and PANC 3 for organ failure
As shown in graph 2, in terms of local complications, all three
models were accurate; however, PANC 3 had the highest
specificity (100%). PANC 3 was seen to be accurately scoring
patients for mortality with highest specificity when compared to
other two models (Graph 3).
Graph 2: Performance of Ranson’s, BISAP and PANC 3 for local
complications
Graph 3: Performance of Ranson’s, BISAP and PANC 3 for mortality
Local complications was present in 13 (24.1%) patients, which
included pseudocyst, necrosis, ascites, walled off necrosis and
recurrence, while 41 patients had no local complications
(p=0.20).
Out of 11 patients, who had clinically severe pancreatitis,
Ranson’s score in 5 of them and BISAP score in 9 of them was
more >/= 3. PANC 3 system did not predict severe pancreatitis
in any cases (score < 3 in all 11 patients). BISAP score of >/= 3
predicted severity of acute pancreatitis significantly (p <0.0000)
when compared to Ranson’s score (p = 0.19) and PANC 3 (p
value could not be calculated), Table 5.
Table 5: Correlation of Predicted scores with observed scores
Score
Actual severity
Total
p value
Ranson’s
Severe
Not severe
>/= 3
5
11
16
0.19
<3
6
32
38
Total
11
43
54
BISAPs
>/= 3
9
3
12
<0.000*
<3
2
40
42
Total
11
43
54
PANC 3
= 3
0
0
0
-
<3
11
43
54
Total
11
43
54
The performance of each scoring model as compared to actual
severity of disease is presented in Table 6. The accuracy of
BISAP, Ranson’s and PANC 3 scoring systems were 91%, 69%
and 79.62%, respectively for predicting the disease severity.
Table 6: Ranson’s, BISAP and PANC 3 scores for predicting disease
severity
Severity
Observation
Sensitivity
Specificity
PPV
NPV
Accuracy
RANSON score
45.45%
74.42%
31.25%
84.21%
69%
BISAP score
81.82%
93.02%
75%
95.24%
91%
PANC 3 score
0
100%
0
79.62%
79.62%
PPV: positive predictive value; NPV: negative predictive value
4. Discussion
Several markers have been validated for predicting the severity
for management of acute pancreatitis [13]. It has been
demonstrated that early recognition of a case can reduce the
mortality rate associated with acute pancreatitis significantly and
also improve outcome [14].
Multifactorial scoring systems such as Ranson’s, Glasgow,
APACHE II, CTSI, BISAP and PANC 3 are most commonly
used wherein various clinical data such as age, etiology and
obesity, blood urea nitrogen, lactate dehydrogenase, chronic
health status and inflammatory markers are also used to predict
the severity. However, owing to various risk factors considered
in each model to define the severity, it is difficult to fully
evaluate the actual sensitivity of the markers applied in
prognosticating the course of the disease [15]. The ideal predictor
of severity is described as being simple, highly sensitive, highly
specific, safe, reproducible, cheap and can be rapidly performed
[16]. The nature and purpose of this research work was to assess
International Journal of Surgery Science http://www.surgeryscience.com
~ 240 ~
the predictive accuracy of Ranson’s criteria, BISAPs and PANC
3 scoring systems in predicting severity of an attack of acute
pancreatitis.
A total of 54 patients with acute pancreatitis were prospectively
studied and it was seen that majority of patients were men
(64.8%). This is in conjunction with findings of other studies
(62%) and it has been shown that alcohol is more common for
pancreatitis in men [17]. In our study, it was also seen that, 43
(79.6%) patients had mild to moderately severe acute
pancreatitis, while 11 (20.4%) patients had severe pancreatitis. 5
out of 11 and 9 out of 11 severe pancreatitis were correctly
predicted by Ranson’s score and BISAP, respectively. While,
PANC 3 did not predict any severe cases.
It was seen that BISAP was the most accurate (78%) in
predicting organ failure. Our results corroborate findings of
studies reported elsewhere. A prospective study of 100 patients,
done by, Lalithkumar et al. [18] showed that BISAP score had
better specificity (95.35%), and diagnostic accuracy (92%) when
compared to Ranson’s model (74.42%, 88% respectively) [18].
Another retrospective study in 303 patients, by Park et al. [19].
showed that BISAP and Ranson’s sensitivity for organ failure
was 91.3% each, specificity was 85% and 71.4 %. PPV was 33.3
and 20.8, NPV was 99.2 and 99.0, respectively. It also showed
that BISAP system predicts severity, death, and organ failure in
acute pancreatitis better than Ranson’s criteria. Results from
current study supports the aforementioned findings.
Additionally, 13 patients in our study reported local
complications like necrosis, ascites, pseudocyst, walled off
necrosis and recurrence of the disease. Among the three models,
Ranson’s score had a higher sensitivity (53.85%) compared to
BISAP (46.15%) whereas PANC3 had highest specificity for
local complications (100%). BISAP and PANC 3 scoring
models were accurate (76%) in predicting local complications.
Park et al. [19] also showed that, for local complications
(particularly necrosis), BISAP and Ranson’s had a sensitivity of
22.5% and 32.5%, specificity of 79.5% and 66.5%, PPV of
14.3% and 12.9% and NPV of 87.1% and 86.6%, respectively.
Another report from Yadav et al. [15] also compared BISAP,
Ranson’s and CTSI in 119 patients prospectively, in predicting
necrosis, mortality and severity. It was seen that BISAP and
Ranson’s were equally sensitive (89.4%) for determining
necrosis, while specificity was higher in BISAP (95.8% versus
94.4%). The PPV was 93.3% and 91.3% for BISAP and
Ranson’s respectively, and NPV was 93.2% for both. The
accuracy of BISAP was 93.4% whereas that of Ranson’s was
92.7%.
In our study, for predicting mortality, Ranson’s and BISAP
scores had a sensitivity of 66.67% and highest specificity was
seen for PANC 3 (100%). We observed that PANC 3 was most
accurate in predicting mortality (94%). Comparable results were
also reported by Park et al. [19] and Yadav et al. [15]. On the
contrary, findings from another study, done by Koziel et al.
reported that BISAP was more accurate in predicting mortality
when compared to PANC 3 and Ranson’s [20]. Furthermore,
Singh V et al. [12], by a prospective study showed better accuracy
with APACHE II compared to BISAP for predicting mortality.
In the current study, it was also seen that the BISAP score was
most accurate amongst all three in predicting clinical severity
with highest sensitivity of 81.82%, PPV and NPV of 75% and
95.24%, respectively. In agreement with our data, BISAP was
seen to be better than Ranson’s for predicting severity in terms
of specificity, PPV, NPV and accuracy, in the study done by
Park et al. [19]. On the other hand, when PANC 3 was compared
with Ranson’s in a study done by Fukuda et al. [21], for
predicting the severity of the disease, it was concluded that
PANC 3 could be used to define the severity and predict acute
pancreatitis, as a method to be used in combination with the
Ranson’s criteria owing to its high accuracy, positive predictive
value and specificity. This hypothesis was further confirmed by
Shah AS et al. [22], wherein PANC 3 was concluded to be a cost-
effective, promising model for predicting severity allowing
prompt treatment and early referral to higher centre.
Although, the various parameters in our study with regard to
Ranson’s, BISAP and PANC 3, for predicting organ failure,
local complications, mortality and clinical severity, had
resemblance to various studies comparing the various scoring
systems, the sample size of our study was small to definitely
predict which scoring system of the three is the best to
accurately predict the clinical severity of acute pancreatitis.
In conclusion, we found that BISAP was better than Ranson’s in
assessing organ failure, local complications, mortality and
clinical severity in terms of sensitivity, specificity, PPV, NPV
and accuracy. BISAP was also better than PANC 3 in all
parameters except specificity, which was highest for PANC 3,
for predicting organ failure, local complications and mortality.
However, the current data does not provide clear guidance on
which models should be used in specific patient population and
further studies with larger sample size are needed to clearly
draw definite conclusions.
Conflict of interest: None
Funding source: None
References
1. McKay CJ, Imrie CW. The continuing challenge of early
mortality in acute pancreatitis. British Journal of Surgery.
2004; 91(10):1243-4.
2. Gloor B, Müller CA, Worni M, Martignoni ME, Uhl W,
Büchler MW. Late mortality in patients with severe acute
pancreatitis. British Journal of Surgery. 2001; 88(7):975-9.
3. Fagenholz PJ, Castillo CF-D, Harris NS, Pelletier AJ,
Camargo CA. Increasing United States Hospital Admissions
for Acute Pancreatitis, 19882003. Annals of
Epidemiology. 2007; 17(7):491.e1-491.e8.
4. Bradley EL. A Clinically Based Classification System for
Acute Pancreatitis. Archives of Surgery. 1993; 128(5):586.
5. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson
CD, Sarr MG et al. Classification of acute pancreatitis-
2012: revision of the Atlanta classification and definitions
by international consensus. Gut. 2013; 62(1):102-11.
6. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K,
Localio SA. Objective early identification of severe acute
pancreatitis. The American journal of gastroenterology.
1974; 61(6):443-51.
7. Larvin M, McMahon MJ. APACHE-II score for assessment
and monitoring of acute pancreatitis. Lancet (London,
England). 1989; 2(8656):201-5.
8. Forsmark CE, Baillie J, AGA Institute Clinical Practice and
Economics Committee, AGA Institute Governing Board.
AGA Institute Technical Review on Acute Pancreatitis.
Gastroenterology. 2007; 132(5):2022-44.
9. Papachristou GI, Muddana V, Yadav D, OʼConnell M,
Sanders MK, Slivka A et al. Comparison of BISAP,
Ransonʼs, APACHE-II, and CTSI Scores in Predicting
Organ Failure, Complications, and Mortality in Acute
Pancreatitis. American Journal of Gastroenterology. 2010;
105(2):435-41.
International Journal of Surgery Science http://www.surgeryscience.com
~ 241 ~
10. Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick
JM, Raraty MG, Slavin J et al. Early prediction of severity
in acute pancreatitis by urinary trypsinogen activation
peptide: a multicentre study. Lancet (London, England).
2000; 355(9219):1955-60.
11. Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks
PA. The early prediction of mortality in acute pancreatitis: a
large population-based study. Gut. 2008; 57(12):1698-703.
12. Singh VK, Wu BU, Bollen TL, Repas K, Maurer R,
Johannes RS et al. A Prospective Evaluation of the Bedside
Index for Severity in Acute Pancreatitis Score in Assessing
Mortality and Intermediate Markers of Severity in Acute
Pancreatitis. The American Journal of Gastroenterology.
2009; 104(4):966-71.
13. Al Mofleh I-A. Severe acute pancreatitis: Pathogenetic
aspects and prognostic factors. World Journal of
Gastroenterology. 2008; 14(5):675.
14. Werner J, Feuerbach S, Uhl W, Büchler MW. Management
of acute pancreatitis: from surgery to interventional
intensive care. Gut. 2005; 54(3):426-36.
15. Yadav J, Yadav SK, Kumar S, Baxla RG, Sinha DK, Bodra
P et al. Predicting morbidity and mortality in acute
pancreatitis in an Indian population: a comparative study of
the BISAP score, Ranson’s score and CT severity index.
Gastroenterology Report. 2016; 4(3):216-20.
16. Abu-Eshy SA, Abolfotouh MA, Nawar E, Abu Sabib A-
RH. Ranson’s criteria for acute pancreatitis in high altitude:
do they need to be modified? Saudi journal of
gastroenterology : official journal of the Saudi
Gastroenterology Association. 2008; 14(1):20-3.
17. Samokhvalov AV, Rehm J, Roerecke M. Alcohol
Consumption as a Risk Factor for Acute and Chronic
Pancreatitis: A Systematic Review and a Series of Meta-
analyses. EBioMedicine. 2015; 2(12):1996-2002.
18. kumar JL, Chitra T, Kodieswaran N. Comparative study
between BISAP and Ranson’s score in predicting severity
of acute pancreatitis. International Archives of Integrated
Medicine. 2016; 3(9):23.
19. Park JY, Jeon TJ, Ha TH, Hwang JT, Sinn DH, Oh T-H et
al. Bedside index for severity in acute pancreatitis:
comparison with other scoring systems in predicting
severity and organ failure. Hepatobiliary & pancreatic
diseases international : HBPD INT. 2013; 12(6):645-50.
20. Koziel D, Gluszek S, Matykiewicz J, Lewitowicz P,
Drozdzak Z. Comparative analysis of selected scales to
assess prognosis in acute pancreatitis. Canadian journal of
gastroenterology & hepatology. 29(6):299-303.
21. Fukuda JK, Franzon O, Resende-Filho F de O, Kruel NF,
Ferri TA. [Prognosis of acute pancreatitis by PANC 3
score]. Arquivos brasileiros de cirurgia digestiva : ABCD =
Brazilian archives of digestive surgery. 2013; 26(2):133-5.
22. Shah AS, Gupta AK, Ded KS. Assessment of PANC3 Score
in Predicting Severity of Acute Pancreatitis. Nigerian
journal of surgery : official publication of the Nigerian
Surgical Research Society. 2017; 23(1):53-7.
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Background: Pancreatitis is a highly prevalent medical condition associated with a spectrum of endocrine and exocrine pancreatic insufficiencies. While high alcohol consumption is an established risk factor for pancreatitis, its relationship with specific types of pancreatitis and a potential threshold have not been systematically examined. Methods: We conducted a systematic literature search for studies on the association between alcohol consumption and pancreatitis based on PRISMA guidelines. Non-linear and linear random-effect dose–response meta-analyses using restricted cubic spline meta-regressions and categorical meta-analyses in relation to abstainers were conducted. Findings: Seven studies with 157,026 participants and 3618 cases of pancreatitis were included into analyses. The dose–response relationship between average volume of alcohol consumption and risk of pancreatitis was monotonic with no evidence of non-linearity for chronic pancreatitis (CP) for both sexes (p = 0.091) and acute pancreatitis (AP) in men (p = 0.396); it was non-linear for AP in women (p = 0.008). Compared to abstention, there was a significant decrease in risk (RR = 0.76, 95%CI: 0.60–0.97) of AP in women below the threshold of 40 g/day. No such association was found in men (RR = 1.1, 95%CI: 0.69–1.74). The RR for CP at 100 g/day was 6.29 (95%CI: 3.04–13.02). Interpretation: The dose–response relationships between alcohol consumption and risk of pancreatitis were monotonic for CP and AP in men, and non-linear for AP in women. Alcohol consumption below 40 g/day was associated with reduced risk of AP in women. Alcohol consumption beyond this level was increasingly detrimental for any type of pancreatitis. Funding: The work was financially supported by a grant from the National Institute on Alcohol Abuse and Alcoholism (R21AA023521) to the last author.
Article
Full-text available
Objective: To evaluate the utility of selected scales to prognosticate the severity and risk for death among patients with acute pancreatitis (AP) according to the revised Atlanta classification published in 2012. Methods: <⁄strong>Prospective data regarding patients hospitalized due to AP were analyzed. The final analysis included a total of 1014 patients. The bedside index for severity in acute pancreatitis (BISAP), Panc 3 scores and Ranson scales were calculated using data from the first 24 h of admission. Results: Mild AP was diagnosed in 822 (81.1%) cases, moderate in 122 (12%) and severe in 70 (6.9%); 38 (3.7%) patients died. The main causes of AP were cholelithiasis (34%) and alcohol abuse (26.7%). Recurrence of AP was observed in 244 (24.1%) patients. In prognosticating the severity of AP, the most useful scale proved to be the Acute Physiology and Chronic Health Evaluation (APACHE) II (area under the curve [AUC] 0.724 [95% CI 0.655 to 0.793]), followed by BISAP (AUC 0.693 [95% CI 0.622 to 0.763]). In prognosticating a moderate versus mild course of AP, the CT severity index proved to be the most decisive (AUC 0.819 [95% CI 0.767 to 0.871]). Regarding prognosis for death, APACHE II had the highest predictive value (AUC 0.726 [95% CI 0.621 to 0.83]); however, a similar sensitivity was observed using the BISAP scale (AUC 0.707 [95% CI 0.618 to 0.797]). Conclusions: Scoring systems used in prognosticating the course of the disease vary with regard to sensitivity and specificity. The CT severity index scoring system showed the highest precision in prognosticating moderately severe AP (as per the revised Atlanta criteria, 2012); however, in prognosticating a severe course of disease and mortality, APACHE II proved to have the greatest predictive value.
Article
Full-text available
Our aim was to prospectively evaluate the accuracy of the bedside index for severity in acute pancreatitis (BISAP) score in predicting mortality, as well as intermediate markers of severity, in a tertiary care centre in east central India, which caters mostly for an economically underprivileged population. A total of 119 consecutive cases with acute pancreatitis were admitted to our institution between November 2012 and October 2014. BISAP scores were calculated for all cases, within 24 hours of presentation. Ranson's score and computed tomography severity index (CTSI) were also established. The respective abilities of the three scoring systems to predict mortality was evaluated using trend and discrimination analysis. The optimal cut-off score for mortality from the receiver operating characteristics (ROC) curve was used to evaluate the development of persistent organ failure and pancreatic necrosis (PNec). Of the 119 cases, 42 (35.2%) developed organ failure and were classified as severe acute pancreatitis (SAP), 47 (39.5%) developed PNec, and 12 (10.1%) died. The area under the curve (AUC) results for BISAP score in predicting SAP, PNec, and mortality were 0.962, 0.934 and 0.846, respectively. Ranson's score showed a slightly lower accuracy for predicting SAP (AUC 0.956) and mortality (AUC 0.841). CTSI was the most accurate in predicting PNec, with an AUC of 0.958. The sensitivity and specificity of BISAP score, with a cut-off of ≥3 in predicting mortality, were 100% and 69.2%, respectively. The BISAP score represents a simple way of identifying, within 24 hours of presentation, patients at greater risk of dying and the development of intermediate markers of severity. This risk stratification method can be utilized to improve clinical care and facilitate enrolment in clinical trials. © The Author(s) 2015. Published by Oxford University Press and the Digestive Science Publishing Co. Limited.
Article
Full-text available
Identification of patients at risk for mortality early in the course of acute pancreatitis (AP) is an important step in improving outcome. Using Classification and Regression Tree (CART) analysis, a clinical scoring system was developed for prediction of in-hospital mortality in AP. The scoring system was derived on data collected from 17,992 cases of AP from 212 hospitals in 2000-2001. The new scoring system was validated on data collected from 18,256 AP cases from 177 hospitals in 2004-2005. The accuracy of the scoring system for prediction of mortality was measured by the area under the receiver operating characteristic curve (AUC). The performance of the new scoring system was further validated by comparing its predictive accuracy with that of Acute Physiology and Chronic Health Examination (APACHE) II. CART analysis identified five variables for prediction of in-hospital mortality. One point is assigned for the presence of each of the following during the first 24 h: blood urea nitrogen (BUN) >25 mg/dl; impaired mental status; systemic inflammatory response syndrome (SIRS); age >60 years; or the presence of a pleural effusion (BISAP). Mortality ranged from >20% in the highest risk group to <1% in the lowest risk group. In the validation cohort, the BISAP AUC was 0.82 (95% CI 0.79 to 0.84) versus APACHE II AUC of 0.83 (95% CI 0.80 to 0.85). A new mortality-based prognostic scoring system for use in AP has been derived and validated. The BISAP is a simple and accurate method for the early identification of patients at increased risk for in-hospital mortality.
Article
Full-text available
Our aim was to prospectively evaluate the ability of the bedside index for severity in acute pancreatitis (BISAP) score to predict mortality as well as intermediate markers of severity in a tertiary center. The BISAP score was evaluated among 397 consecutive cases of acute pancreatitis admitted to our institution between June 2005 and December 2007. BISAP scores were calculated on all cases using data within 24 h of presentation. The ability of the BISAP score to predict mortality was evaluated using trend and discrimination analysis. The optimal cutoff score for mortality from the receiver operating curve was used to evaluate the development of organ failure, persistent organ failure, and pancreatic necrosis. Among 397 cases, there were 14 (3.5%) deaths. There was a statistically significant trend for increasing mortality (P < 0.0001) with increasing BISAP score. The area under the receiver operating curve for mortality by BISAP score in the prospective cohort was 0.82 (95% confidence interval: 0.70, 0.95), which was similar to that of the previously published validation cohort. A BISAP score >or=3 was associated with an increased risk of developing organ failure (odds ratio=7.4, 95% confidence interval: 2.8, 19.5), persistent organ failure (odds ratio=12.7, 95% confidence interval: 4.7, 33.9), and pancreatic necrosis (odds ratio=3.8, 95% confidence interval: 1.8, 8.5). The BISAP score represents a simple way to identify patients at risk of increased mortality and the development of intermediate markers of severity within 24 h of presentation. This risk stratification capability can be utilized to improve clinical care and facilitate enrollment in clinical trials.
Article
Full-text available
The value of the Acute Physiology and Chronic Health Enquiry (APACHE-II) score, the Simplified Acute Physiology score, and the Medical Research Council (MRC) sepsis score were compared with clinical assessment and Ranson and Imrie scores in the evaluation and monitoring of acute pancreatitis in 290 attacks. Attacks were graded mild (231) if uncomplicated, or severe (59) when major organ failure or a pancreatic collection occurred. Only APACHE-II scores were available at the time of admission; they correctly predicted outcome in 77% of attacks and identified 63% of severe attacks, compared with 44% achieved by clinical assessment. After 48 h, APACHE-II was most accurate, and correctly predicted outcome in 88% of attacks, compared with 69% for Ranson and 84% for Imrie scores. APACHE-II predicted 73% of pancreatic collections at 48 h, compared with 65% for Ranson and 58% for Imrie scores. In acute pancreatitis, APACHE-II may facilitate rapid selection of patients for intensive therapy or clinical trials, improve comparison between groups of patients, and indicate that a pancreatic collection is probable.
Article
Background and objective The Atlanta classification of acute pancreatitis enabled standardised reporting of research and aided communication between clinicians. Deficiencies identified and improved understanding of the disease make a revision necessary. Methods A web-based consultation was undertaken in 2007 to ensure wide participation of pancreatologists. After an initial meeting, the Working Group sent a draft document to 11 national and international pancreatic associations. This working draft was forwarded to all members. Revisions were made in response to comments, and the web-based consultation was repeated three times. The final consensus was reviewed, and only statements based on published evidence were retained. Results The revised classification of acute pancreatitis identified two phases of the disease: early and late. Severity is classified as mild, moderate or severe. Mild acute pancreatitis, the most common form, has no organ failure, local or systemic complications and usually resolves in the first week. Moderately severe acute pancreatitis is defined by the presence of transient organ failure, local complications or exacerbation of co-morbid disease. Severe acute pancreatitis is defined by persistent organ failure, that is, organ failure >48?h. Local complications are peripancreatic fluid collections, pancreatic and peripancreatic necrosis (sterile or infected), pseudocyst and walled-off necrosis (sterile or infected). We present a standardised template for reporting CT images. Conclusions This international, web-based consensus provides clear definitions to classify acute pancreatitis using easily identified clinical and radiologic criteria. The wide consultation among pancreatologists to reach this consensus should encourage widespread adoption.
Article
The early identification of severe acute pancreatitis is important for the management and for improving outcomes. The bedside index for severity in acute pancreatitis (BISAP) has been considered as an accurate method for risk stratification in patients with acute pancreatitis. This study aimed to evaluate the comparative usefulness of the BISAP. We retrospectively analyzed 303 patients with acute pancreatitis diagnosed at our hospital from March 2007 to December 2010. BISAP, APACHE-II, Ranson criteria, and CT severity index (CTSI) of all patients were calculated. We stratified the number of patiants with severe pancreatitis, pancreatic necrosis, and organ failure as well as the number of deaths by BISAP score. We used the area under the receiver-operating curve (AUC) to compare BISAP with other scoring systems, C-reactive protein (CRP), hematocrit, and body mass index (BMI) with regard to prediction of severe acute pancreatitis, necrosis, organ failure, and death. Of the 303 patiants, 31 (10.2%) were classified as having severe acute pancreatitis. Organ failure occurred in 23 (7.6%) patients, pancreatic necrosis in 40 (13.2%), and death in 6 (2.0%). A BISAP score of 2 was a statistically significant cutoff value for the diagnosis of severe acute pancreatitis, organ failure, and mortality. AUCs for BISAP predicting severe pancreatitis and death were 0.80 and 0.86, respectively, which were similar to those for APACHE-II (0.80, 0.87) and Ranson criteria (0.74, 0.74) and greater than AUCs for CTSI (0.67, 0.42). The AUC for organ failure predicted by BISAP, APACHE-II, Ranson criteria, and CTSI was 0.93, 0.95, 0.84 and 0.57, respectively. AUCs for BISAP predicting severity, organ failure, and death were greater than those for CRP (0.69, 0.80, 0.72), hematocrit (0.45, 0.35, 0.14), and BMI (0.41, 0.47, 0.17). The BISAP predicts severity, death, and especially organ failure in acute pancreatitis as well as APACHE-II does and better than Ranson criteria, CTSI, CRP, hematocrit, and BMI.
Article
One hundred consecutive patients with acute pancreatitis have been evaluated. Fifteen patients died and 16 were seriously ill requiring over one week of intensive care. Pancreatitis was associated with alcoholism in 74, biliary tract disease in 14 and other etiologies in 12 patients. Statistical analysis of 43 early objective findings identified 11 that were of significant prognostic value. Death or serious illness correlated with: on admission: age, over 55 years; blood glucose, over 200 mg%; white blood cell count, over 16,000/cu mm; LDH, over 700 IU% and SGOT, over 250 Sigma Frankel u%; or during initial 48 hours of therapy: hematocrit decrease, over 10 percentage points; serum calcium, below 8 mg%; base deficit, over 4 mEq/l; blood urea nitrogen, increase over 5 mg%; fluid sequestration, over 6 l and arterial PO2 below 60 ml of mercury. Plain admission X-rays of the chest and abdomen were evaluated in 73 of these patients and the incidence of nine radiographic signs assessed. These were gastrocolic separation, gastric greater curvature distortion, duodenal ileus, segmental small bowel ileus, colonic dilatation, obscured psoas margins, increased epigastric soft tissue density, pleural effusion and pancreatic calcification. Radiographic signs were present in 79% of patients and although they may provide valuable diagnostic information, correlation with prognosis is poor.